PPIs in Noncirrhotic Patients With Chronic HCV Infection PPIs in Noncirrhotic Patients With Chronic HCV Infection

This study assessed the impact of proton pump inhibitors on the progression of liver disease in noncirrhotic patients with hepatitis C virus infection. Are PPIs safe to use in these patients?Alimentary Pharmacology & Therapeutics
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news